Documents & Downloads

Remigromig

Bispecific Monoclonal Antibody

Remigromig is a humanized bispecific monoclonal antibody that simultaneously targets LRP5 and FZD4. This molecule is primarily utilized in research focused on macular degeneration, offering potential insights into the mechanistic pathways involved in this condition. Its unique dual-targeting capability may facilitate the investigation of therapeutic strategies aimed at retinal health and disease.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
CAS Number	3059389-31-7
Applications	Bispecific Monoclonal Antibody
Synonyms	SZN-413

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.